Name
Aktsiaselts MAGNUM
Registry code
12371718
VAT number
EE101106531
Type
AS - Joint Stock Company
Status
Registered
Foundation date
01.11.2012 (13)
Financial year
01.05-30.04
Capital
25 000.00 €
Activity
82991 - Other business support service activities n.e.c. 70221 - Business and other management consultancy activities 63111 - Data processing, hosting and related activities 77401 - Leasing of intellectual property and similar products, except copyrighted works 69202 - Bookkeeping, tax consulting
10 827 832 €
-362 433 €
-3%
3 943 €
(estimate is approximate)
80 886 264 €
82
Submitted
No tax arrears
-0%
-0%
| Owner | Representative | Beneficial owner | |
|---|---|---|---|
| Omanikukonto: MARGUS LINNAMÄE
| - | - | Indirect ownership |
| Marika Pensa
| - | Board member | - |
| Mari Krass
| - | Board member | - |
| Kristina Toms
| - | Board member | - |
| MM Pharma OÜ 14080511 | 100% - 25 000.00 EUR | - | - |
| Owner | Representative | Beneficial owner | |
|---|---|---|---|
| Magnum Dental OÜ 10351798 | 75% - 7 500.00 EUR | - | - |
| MAGNUM LOGISTICS OÜ 11331792 | 100% - 2 556.00 EUR | - | - |
| MAGNUM MEDICAL OÜ 11332521 | 100% - 2 556.00 EUR | - | - |
| Allium UPI OÜ 11331786 | 100% - 2 556.00 EUR | - | - |
| TPA Narva Apteegid OÜ 14160210 | 100% - 2 500.00 EUR | - | - |
| Allium Pharma OÜ 14192368 | 100% - 2 500.00 EUR | - | - |
| Apteegi Beauty OÜ 14416750 | 100% - 2 500.00 EUR | - | - |
| OÜ Narva-Jõesuu Apteek 11820456 | 49% - 2 454.00 EUR | - | - |
| Aktsiaselts Magnum Veterinaaria 10007517 | 100% - 223 051.00 EUR | - | - |
| 2019 30.10.2020 | 2020 30.10.2021 | 2021 30.10.2022 | 2022 30.10.2023 | 2023 30.10.2024 | 2024 30.10.2025 | |
|---|---|---|---|---|---|---|
| Total Revenue | 5 754 856 € | 5 768 198 € | 6 585 102 € | 7 128 955 € | 10 353 152 € | 10 827 832 € |
| Net profit (loss) for the period | -70 300 € | -242 175 € | -137 303 € | 921 107 € | -127 464 € | -362 433 € |
| Profit Margin | -1% | -4% | -2% | 13% | -1% | -3% |
| Current Assets | 986 168 € | 1 427 931 € | 2 614 057 € | 3 851 711 € | 9 856 060 € | 17 624 960 € |
| Fixed Assets | 137 850 500 € | 142 722 560 € | 150 524 160 € | 177 330 340 € | 160 627 730 € | 144 905 390 € |
| Total Assets | 138 836 660 € | 144 150 480 € | 153 138 220 € | 181 182 050 € | 170 483 790 € | 162 530 350 € |
| Current Liabilities | 1 096 754 € | 2 687 757 € | 1 810 797 € | 10 104 656 € | 35 826 148 € | 25 905 142 € |
| Non Current Liabilities | 32 770 000 € | 36 735 000 € | 46 737 000 € | 65 565 856 € | 53 408 948 € | 55 738 948 € |
| Total Liabilities | 33 866 754 € | 39 422 757 € | 48 547 797 € | 75 670 512 € | 89 235 096 € | 81 644 090 € |
| Share Capital | 25 000 € | 25 000 € | 25 000 € | 25 000 € | 25 000 € | 25 000 € |
| Equity | 104 969 904 € | 104 727 730 € | 104 590 424 € | 105 511 536 € | 81 248 696 € | 80 886 264 € |
| Employees | 63 | 67 | 71 | 76 | 82 | 82 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2025 Q4 | - | 657 002 € | 684 067 € | 79 |
| 2025 Q3 | - | 549 929 € | 581 739 € | 79 |
| 2025 Q2 | - | 572 678 € | 599 530 € | 79 |
| 2025 Q1 | - | 495 801 € | 505 840 € | 78 |
| 2024 Q4 | - | 647 138 € | 675 348 € | 79 |
| 2024 Q3 | - | 466 286 € | 492 471 € | 79 |
| 2024 Q2 | - | 427 026 € | 438 963 € | 79 |
| 2024 Q1 | - | 459 563 € | 469 709 € | 76 |
| 2023 Q4 | - | 797 195 € | 813 399 € | 79 |
| 2023 Q3 | - | 461 336 € | 477 902 € | 79 |
| 2023 Q2 | - | 405 269 € | 414 597 € | 72 |
| 2023 Q1 | - | 381 690 € | 397 292 € | 72 |
| 2022 Q4 | - | 460 717 € | 471 506 € | 67 |
| 2022 Q3 | - | 353 772 € | 371 648 € | 67 |
| 2022 Q2 | - | 317 994 € | 330 082 € | 67 |
| 2022 Q1 | - | 302 043 € | 313 615 € | 70 |
